Issue Detection and Escalation in Clinical Trial Settings

This webinar on issue detection and escalation in clinical trial settings will review the responsibilities of sponsors, investigators, IRB, vendors and CROs in clinical trial setting to maintain compliance. We will discuss how you can proactively monitor to prevent issues and in case of issue detection, escalate them.

Who will Benefit:

- Clinical operations
- Project managers
- Clinical Research Associates (CRA)
- Clinical Trial Associates (CTA)
- Medical monitors
- Pharmacovigilance specialists
- Site managers
- Principle Investigators

John (Jack) McLane, Ph.D. COO and VP of Clinical and Regulatory Affairs at Clinquest, Inc. has over 25 years of experience in the pharmaceutical and medical device with both large and small pharmaceuticals and CRO. He has been directly involved in over 100 clinical studies, filed numerous INDs/ IDEs and three NDA/MAA submissions.

• Conferences & Trade Shows Today